In a year when the public and political spotlight was already focused squarely on health care, the Covid-19 pandemic has intensified the level of scrutiny on the industry. While sentiment toward the industry has largely improved, the outbreak has also prompted conversations about the structural shortcomings of the current system. Although the issues of coverage and affordability remain at the forefront, Covid-19 has introduced a new dimension—resilience—to the discussion as well.
This executive briefing examines the emerging focus on resilience by breaking down how purchaser motivations are (and aren’t) shifting—and how the core structural elements of the delivery system must evolve as a result of the Covid-19 pandemic.
Download the PDF below to learn the top 16 insights about the state of the health care industry in the wake of the Covid-19 pandemic.
